SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-148060
Filing Date
2017-04-28
Accepted
2017-04-28 16:01:06
Documents
2
Period of Report
2017-06-20
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A d386244ddef14a.htm DEF 14A 353646
2 GRAPHIC g386244g54l52.jpg GRAPHIC 19971
  Complete submission text file 0001193125-17-148060.txt   382361
Mailing Address 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37539 | Film No.: 17795299
SIC: 2834 Pharmaceutical Preparations